Reducing HIV and AIDS in adolescents: Opportunities and challenges

Current HIV/AIDS Reports

Volumn 10, Issue 2, 2013, Pages 159-168

  Kasedde, Susan ^a   Luo, Chewe ^a   McClure, Craig ^a   Chandan, Upjeet ^a  

^a UNICEF   (United States)

Author keywords

Adolescence; Adolescent; Adolescents; Effectiveness; Gender; Girls; HIV AIDS; Injecting drug use; Investment; Key affected populations; Living with HIV; Males who have sex with males; Sexual exploitation

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT DISEASE; ARTICLE; CENTRAL AMERICA; EASTERN EUROPE; EPIDEMIC; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MIDDLE EAST; NORTH AFRICA; SEXUAL TRANSMISSION; SEXUAL VIOLENCE; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; SOUTH ASIA; SOUTHEAST ASIA; SUSTAINABLE DEVELOPMENT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT HEALTH SERVICES; CHILD; DIRECTIVE COUNSELING; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV SEROPOSITIVITY; HUMANS; MALE; NEEDS ASSESSMENT; POPULATION SURVEILLANCE; RISK-TAKING; UNITED STATES; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84883053016     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-013-0159-7     Document Type: Article

References (78)

1. WHO: The second decade: improving adolescent health and development. Department of Child and Adolescent Health and Development. Geneva: WHO. 2001.
2. Patton G, McMorris BJ, Toumbourou JW, et al. Puberty and the onset of substance use. Pediatrics. 2004;114:300-6.
3. WHO, UNFPA, and UNAIDS. Seen but not heard: very young adolescents aged 10-14 years. Geneva: UNAIDS. 2004.
4. Viner RM, Ozer EM, Denny S, et al. Adolescence and the social determinants of health. Lancet. 2012;379:1641-52.
5. UNICEF. Opportunity in crisis: Preventing HIV from early adolescence to early adulthood. New York: UNICEF; 2011.
6. UNICEF. Progress for children: A report card on adolescents. New York: UNICEF; 2012.
7. WHO. Early marriages, adolescent, and young pregnancies, WHO Report to the 65th World Health Assembly. 2012.
8. WHO Fact Sheet No 364. Adolescent pregnancy. 2012.
9. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. Geneva: UNAIDS; 2012.
10. UNAIDS. Unpublished 2011 Estimates. Geneva: UNAIDS. 2012.
11. UNICEF, Blame and Banishment. The underground HIV epidemic affecting children in Eastern Europe and Central Asia. Switzerland: UNICEF. 2010.
12. National Center for AIDS and STD Control (NCASC) Integrated Biological and Behavioral Surveillance (IBBS) 2011 Round V, Injecting Drug Users. Kathmandu and Pokhara Valleys Fact Sheet. Accessed February 21, 2013 http://www.ncasc. gov.np/uploaded/facts-n-figure/IBBS-2011/2011-IBBS-IDUs-Factsheet.pdf.
13. US Centers for Disease Control and Prevention. HIV and young men who have sex with men, May 2012 Accessed Feb 21, 2012. http://www.cdc.gov/healthyyouth/ sexualbehaviors/pdf/hiv-factsheet-ymsm.pdf
14. Beyrer C, Baral S, van Griensven F, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380:367-77.
15. Millett G, Jeffries IV WL, Peterson JL, et al. Common roots: a contextual review of HIV epidemics in black men who have sex with men across the African diaspora. Lancet. 2012;380:411-23.
16. US Centers for Disease Control and Prevention, HIV Among Youth in the US: protecting a generation, in CDC vital signs. November 2012.
17. Birdthistle I, Dringus S, Knight L, et al. Investing in young people: a review of national-level spending on HIV prevention for young people aged 10-24 in 16 high-prevalence countries. Presented at the XIX International AIDS Conference. Washington DC, United States of America. 2012.
18. • Deogan C, Ferguson J, Stenberg K. Resource needs for adolescent friendly health services: estimates for 74 low- and middle-income countries. PLoS One. 2012;7:e51420. Estimates additional resource needs for scaling up health service delivery to adolescents to achieve MDG 4, 5, and 6 by 2015, indicating a substantial investment gap in the adolescent HIV and health response in low and middle income countries.
19. •• Schwartlander B, Stover J, Hallett T, et al. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet. 2011;377:2031-41. Makes a strong, evidence-based argument for a more targeted and strategic investment approach to reduce HIV risk, transmission, morbidity, and mortality, with broad-based population impacts.
20. Guttmacher Institute and IPPF. In brief: Facts on the sexual and reproductive health of adolescent women in the developing world. New York: Guttmacher Institute; 2010.
21. Sweeney S, Obure CD, Maier CB, et al. Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience. Sex Transm Infect. 2012;88:85-99.
22. Fortenberry JD, Martinez J, Rudy BJ, Monte D. Linkage to care for HIV-positive adolescents: a multi-site study of the Adolescent Medicine Trials Unit of the Adolescent Trials Network. J Adolesc Health. 2012;51:551-6.
23. Kenny J, Mulenga V, Hoskins S, et al. The needs for HIV treatment and care of children, adolescents, pregnant women, and older people in low-income and middle-income countries. AIDS 2012;(Suppl 2):S105-16.
24. Leclerc-Madlala S. Age-disparate and intergenerational sex in southern Africa: the dynamics of hypervulnerability. AIDS. 2008;22 Suppl 4:S17-25.
25. Underwood C, Skinner J, Osman N, Schwandt H. Structural determinants of adolescent girls' vulnerability to HIV: views from community members in Botswana, Malawi, and Mozambique. Soc Sci Med. 2011;73:343-50.
26. •• Baird S, Garfein R, Mcintosh C, Ozler B. Effect of a cash transfer program for schooling on prevalence of HIV and herpes simplex type 2 in Malawi: a cluster randomized trial. Lancet. 2012;379:1320-9. Demonstrates how cash transfer programs (structural intervention) that do not directly target sexual behavior can reduce HIV and HSV-2 infections in adolescent schoolgirls in low income settings.
27. Andersson N, Paredes-Solís S, Milne D, et al. Prevalence and risk factors for forced or coerced sex among school-going youth: national cross-sectional studies in 10 southern African countries in 2003 and 2007. BMJ Open. 2012;2:e000754. doi: 10.1136/bmjopen-2011-000754.
28. Andersson N, Cockroft A. Gender-based violence and HIV: relevance for HIV prevention in hyperendemic countries of southern Africa. AIDS. 2008;22 Suppl 4:S73-86.
29. Merkinaite S, Grund JP, Frimpong A. Young people and drugs: next generation of harm reduction. Int J Drug Policy. 2010;21:112-4.
30. Rhodes T, Simic M. Transition and the HIV risk environment. BMJ. 2005;331:220-3.
31. European Bank for Reconstruction and Development, Transition report. Energy in transition - economic transition in central and eastern Europe, the Baltic states, and the CIS. EBRD: London; 2001.
32. Hillis SD, Zapata L, Robbins CL, et al. HIV seroprevalence among orphaned and homeless youth: no place like home. AIDS. 2012;26:105-10.
33. Robbins CL, Zapata L, Kissin DM, et al. Multicity HIV seroprevalence in street youth, Ukraine. Int J STD AIDS. 2010;21:489-96.
34. Kissin DM, Zapata L, Yorick R, et al. HIV seroprevalence in street youth, St. Petersburg, Russia. AIDS. 2007;21:2333-40.
35. Thorne C, Semenenko I, Malyuta R. Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10. Addiction. 2012;107:118-28.
36. Silverman JG. Adolescent female sex workers: invisibility, violence, and HIV. Arch Dis Child. 2011;96:478-81.
37. Zhang XD, Temmerman M, Li Y, et al. Vulnerabilities, health needs, and predictors of high-risk sexual behavior among female adolescent sex workers in Kunming, China. Sex Transm Infect. 2012;1-8.
38. FHI, Young People Most at Risk of HIV. A meeting report and discussion paper from the Interagency Working Group, U.S. Agency for International Development, the Joint United Nations Programme on HIV/AIDS (UNAIDS) Inter-Agency Task Team on HIV, and Young People, and FHI. FHI: Research Triangle Park. 2010.
39. Smyrnov P, Broadhead RS, Datsenko O, Matiyash O. Rejuvenating harm reduction projects for injection drug users: Ukraine's nationwide introduction of peer-driven interventions. Int J Drug Policy. 2012;23:141-7.
40. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic, and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51:65-71.
41. Mbori-Ngacha D. Follow-up and adherence management for children and adolescents living with HIV, in from the ground up: establishing a framework for success. Elizabeth Glazier Pediatric AIDS Foundation. 2004;885-6. http://ftguonline.org/ftgu-232/index.php/ftgu/index. Accessed 9 Jan 2013.
42. Birungi H, Mugisha JF, Obare F, Nyombi JK. Sexual behavior and desires among adolescents perinatally infected with human immunodeficiency virus in Uganda: implications for programming. J Adolesc Health. 2009;44:184-7.
43. Birungi H, Obare F, Mugisha JF, et al. Preventive service needs of young people perinatally infected with HIV in Uganda. AIDS Care. 2009;21:725-31.
44. Hodgson I, Ross J, Haamujompa C, Gitau-Mburu D. Living as an adolescent with HIV in Zambia-lived experiences, sexual health, and reproductive needs. AIDS Care. 2012;24:1204-10.
45. Ferrand RA, Bandason T, Musvaire P. Causes of acute hospitalization in adolescence: burden and spectrum of HIV-related morbidity in a country with an early-onset and severe HIV epidemic: a prospective survey. PLoS Med. 2010;7:e1000178. doi: 10.1371/journal.pmed.1000178.
46. •• Ferrand RA, Munaiwa L, Matsekete J, et al. Undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe. Clin Infect Dis. 2010;51:844-51. Reports high rates of undiagnosed HIV infection among adolescents seeking primary health care in Zimbabwe, emphasizing the importance of routine HIV testing and counselling at the primary care level to identify vertically-infected adolescents ('slow progressors') and link them to treatment and care.
47. Binagwaho A, Fuller A, Farmer P, et al. Adolescents and the right to health: eliminating age-related barriers to HIV/AIDS services in Rwanda. AIDS Care. 2012;24:936-42.
48. Ferrand RA, Trigg C, Bandason T, et al. Perception of risk of vertically acquired HIV infection and acceptability of provider-initiated testing and counselling among adolescents in Zimbabwe. Am J Public Health. 2011;01:2325-32.
49. van Rooyen H, McGrath N, Chirowodza A, et al. Mobile VCT. Reaching men and young people in urban and rural South African pilot studies (NIMH Project Accept, HPTN 043). AIDS Behav. 2012;[epub ahead of print].
50. Ramirez-Avila L, Nixon K, Noubary F, et al. Routine HIV testing in adolescents and young adults presenting to an outpatient clinic in Durban, South Africa. PLoS One. 2012;7:e45507.
51. Li R, Jaspan H, O'Brien V, et al. Positive futures: a qualitative study on the needs of adolescents on antiretroviral therapy in South Africa. AIDS Care. 2010;22:751-8.
52. Dowshen N, D'Angelo L. Health care transition for youth living with HIV/AIDS. Pediatrics. 2011;128:762-71.
53. Koenig LJ, Nesheim S, Abramowitz S. Adolescents with perinatally acquired HIV: emerging behavioral and health needs for long-term survivors. Curr Opin Obstet Gynecol. 2011;23:321-7.
54. Kim J, Pronyk J, Barnett T, Watts C. Exploring the role of economic empowerment in HIV prevention. AIDS. 2008;22 Suppl 4:S57-71.
55. Chersich MF, Rees HV. Vulnerability of women in southern Africa to infection with HIV: biological determinants and priority health sector interventions. AIDS. 2008;22 Suppl 4:S27-40.
56. Interagency Task Team on HIV and Young People Guidance Brief. HIV Interventions for Most-at-Risk Young People. New York: UNFPA. 2009.
57. Bailey C, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet. 2007;369:643-56.
58. Gray H, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in young men in Rakai, Uganda: a randomized trial. Lancet. 2007;369:657-66.
59. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2:e298.
60. World Health Organization. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: WHO; 2004.
61. •• Grant RL, Grant RM, Lama JR, Anderson PL, et al. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-99. Article presents findings from the first successful trial testing the proof of concept of use of oral daily combination pre-exposure prophylaxis in 2 high risk populations (MSM and transgender women).
62. WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Recommendations for a public health approach. Geneva: WHO; 2010.
63. Cohen MS, Gay CL. Treatment to prevent transmission of HIV-1. Clin Infect Dis. 2010;50 Suppl. 3:S85-95.
64. •• Cohen MS, McCauley M, Gamble TR. HIV treatment as prevention and HPTN 052. Curr Opin HIV AIDS. 2012;7:99-105. Article describes the seminal randomized controlled trial proving 96 % reduction in sexual transmission of HIV in sero-discordant heterosexual couples through the use of antiretroviral therapy.
65. Shepherd J, Kavanagh J, Picot, J, et al. The effectiveness and cost-effectiveness of behavioral interventions for the prevention of sexually transmitted infections in young people aged 13-19: a systematic review and economic evaluation, Health Technology Assessment. 2010:14.
66. Vidanapathirana J, Abramson MJ, Forbes A, Fairley C. Mass media interventions for promoting HIV testing. Cochrane Database Syst Rev. 2005;3:CD004775.
67. •• Karim QA, Karim SSA, et al. Effectiveness and safety of Tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-74. Article presents the findings of the first successful trial showing that the use of Tenofovir based vaginal microbicide gel reduced the risk of HIV acquisition by 39 % including some as young as 18. The gel had a higher effectiveness (54 %) in women who adhered to the guidelines provided.
68. Celum C, Baeten JM. Tenofovir-based pre-exposure prophylaxis for HIV prevention: evolving evidence. Curr Opin Infect Dis. 2012;25:51-7.
69. US Centers for Disease Control and Prevention: HIV surveillance in adolescents and adults. Accessed March 7, 2013. http://www.cdc.gov/hiv/topics/ surveillance/resources/slides/adolescents/index.htm.
70. WHO (2006) Global estimates of health consequences due to violence against children. Background paper to the UN Secretary-General's Study on Violence against Children. Geneva, World Health Organization, based on estimates by Andrews G, et al. (2004). Child Sexual Abuse. Ch. 23 in Ezzati M, et al. (2004). Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, Vol 2. Geneva, World Health Organization, pp. 1851-940, and using UN Population Division data for the population under 18 years.
71. Strode A, Grant K. Children and HIV: using an evidence-based approach to identifying legal strategies that protect and promote the right of children infected and affected by HIV and AIDS, Working paper prepared for the Third Meeting of the Technical Advisory Group of the Global Commission on HIV and the Law. 2011.
72. Ferrand R, Lowe S, et al. Survey of children accessing HIV services in a high HIV prevalence setting: time for HIV-infected adolescents to count? Bull WHO 2010;6:428-34.
73. Fay H, Baral SD, et al. Stigma, health care access, and HIV knowledge among men who have sex with men in Malawi, Namibia, and Botswana. AIDS Behav. 2011;15:1088-97.
74. Baral S, Sifakis F, et al. Elevated risk for HIV infection among men who have sex with men in low- and middle income countries 2000-2006: a systematic review. PLoS Med. 2007;4:e339.
75. Baral SD, Poteat T, et al. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:214-22.
76. Sullivan PS, Carballo-Dieguez A, et al. Successes and challenges of HIV prevention in men who have sex with men. Lancet. 2012;380:388-99.
77. Baggaley RF, White RG, et al. HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention. Int J Epidemiol. 2010;39:1048-63.
78. WHO. Guidelines: Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people: Recommendations for a public health approach. 2011.